Search hospitals > Pennsylvania > Philadelphia
Abramson Cancer Center of the University of Pennsylvania
Claim this profilePhiladelphia, Pennsylvania 19104
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Lymphoma
Conducts research for Leukemia
947 reported clinical trials
71 medical researchers
Summary
Abramson Cancer Center of the University of Pennsylvania is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Lymphoma, Leukemia and other specialties. Abramson Cancer Center of the University of Pennsylvania is involved with conducting 947 clinical trials across 634 conditions. There are 71 research doctors associated with this hospital, such as Arati Desai, MD, Amy Clark, Lainie P. Martin, and Thomas Karasic, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Arati Desai, MDAbrams Cancer Center of the University of Pennsylvania5 years of reported clinical research
Studies Glioblastoma
Studies Brain Tumor
10 reported clinical trials
21 drugs studied
Amy ClarkUniversity of Pennsylvania1 year of reported clinical research
Studies Breast Cancer
Studies Tumors
10 reported clinical trials
29 drugs studied
Lainie P. MartinUniversity of Pennsylvania4 years of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
9 reported clinical trials
18 drugs studied
Thomas Karasic, MDUniversity of Pennsylvania3 years of reported clinical research
Studies Cancer
Studies Colorectal Cancer
9 reported clinical trials
17 drugs studied
Clinical Trials running at Abramson Cancer Center of the University of Pennsylvania
Breast Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Adenocarcinoma
Esophageal Carcinoma
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Tumors
Ovarian Cancer
Lymphoma
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
The primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) versus treatment of physician's choice (TPC) in participants with previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do not express programmed cell death ligand 1 (PD-L1) or in participants previously treated with anti-programmed cell death (ligand or protein) 1 (Anti-PD-(L)1) Agents in the early setting whose tumors do express PD-L1.
Recruiting4 awards Phase 3
Sacituzumab Govitecan + Pembrolizumab
for Triple-Negative Breast Cancer
The primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) and pembrolizumab versus treatment of physician's choice (TPC) and pembrolizumab in participants with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors express programmed cell death ligand 1 (PD-L1).
Recruiting4 awards Phase 3
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Abramson Cancer Center of the University of Pennsylvania?
Abramson Cancer Center of the University of Pennsylvania is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Lymphoma, Leukemia and other specialties. Abramson Cancer Center of the University of Pennsylvania is involved with conducting 947 clinical trials across 634 conditions. There are 71 research doctors associated with this hospital, such as Arati Desai, MD, Amy Clark, Lainie P. Martin, and Thomas Karasic, MD.
Where is Abramson Cancer Center of the University of Pennsylvania located?
**Directions to Abramson Cancer Center, University of Pennsylvania, Philadelphia:**
- Take I-76 East to Exit 346B, University Avenue.
- Turn right onto Civic Center Boulevard.
- For real-time driving directions based on current traffic, consider using Waze.
Who should I call to ask about financial aid or insurance network?
**Abramson Cancer Center of the University of Pennsylvania - Financial and Insurance Assistance**
- **Financial Counseling Assistance:** Contact Tonya Boyer via email at Tonya.Boyer@pennmedicine.upenn.edu or by phone at 610-738-2510.
- **Insurance-Related Inquiries:** Reach out to Penn Medicine's customer service at 800-406-1177.
- **General Questions about Navigating Cancer Care:** Call 800-789-7366 (PENN).
What insurance does Abramson Cancer Center of the University of Pennsylvania accept?
The Abramson Cancer Center of the University of Pennsylvania accepts most major insurance plans. Patients are advised to confirm their insurance coverage with their provider before receiving care. Penn Medicine, including the Abramson Cancer Center, offers comprehensive care under various health plans, covering cancer and heart conditions.
What awards or recognition has Abramson Cancer Center of the University of Pennsylvania received?
The Abramson Cancer Center at the University of Pennsylvania is renowned for its exceptional cancer care, earning accolades from the Commission on Cancer (CoC). In 2023, four of its researchers were distinguished with prestigious awards from the American Association for Cancer Research (AACR).